Movement disorders News and Research

RSS

Trichloroethylene chemical - widely used in industry - is a risk factor for parkinsonism

Parkinson's disease, the most common neurodegenerative movement disorder caused by aging, can also be caused by pesticides and other neurotoxins.

8 Jan 2008

Researchers establish risk factors for Parkinson's disease

Doctors know an impaired sense of smell is an early indicator of Parkinson's Disease.

8 Jan 2008

Lower frequency deep brain stimulation effective treatment for dystonia

A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.

25 Oct 2007

Researchers report most complete list so far of the proteins present in the cerebral cortex

Researchers report in the October 2007 issue of Molecular & Cellular Proteomics the most complete list so far of the proteins present in the cerebral cortex – the outermost layer of the brain that plays a central role in memory, language, cognition, and consciousness.

8 Oct 2007

Ovary removal before menopause leads to memory and movement problems

Women who have their ovaries removed before menopause are at an increased risk of developing memory problems or dementia and movement disorders such as Parkinson's disease, according to two studies published August 29, 2007, in the online edition of Neurology, the medical journal of the American Academy of Neurology.

30 Aug 2007

Researchers use 'genomic pathway' to predict Parkinson's

A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.

17 Jun 2007

Myelin and Huntington's disease

Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer's Disease Clinic, suggested in the journal Alzheimer's & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer's disease.

14 Jun 2007

Catastrophic events affect the quality and the quantity of a person's sleep

A significant disruption of day-to-day life can take place in those areas affected by a natural disaster.

14 Jun 2007

Sleep disorder diagnosis and treatment

Jeffrey Kopita, M.D., pulmonologist and sleep medicine specialist on the medical staff at Baylor Medical Center at Garland, talks about sleep disorder diagnosis and treatment.

8 Jun 2007

Better understanding of deep brain stimulation

Brain "pacemakers" that have helped ease symptoms in people with Parkinson's disease and other movement disorders seem to work by drowning out the electrical signals of their diseased brains.

1 Jun 2007

Common antipsychotic drug for methamphetamine overdose may damage brain cells

A common antipsychotic drug used in emergency rooms to treat methamphetamine overdose damages nerve cells in an area of the brain known to regulate movement, a new study shows.

30 May 2007

Exercise shows beneficial effects in patients with Parkinson's disease

A new study from researchers at the Keck School of Medicine of the University of Southern California (USC) shows that treadmill exercises may benefit patients with Parkinson's Disease and those with similar movement disorders.

16 May 2007

CleveMed receives approval to market motor assessment system

Cleveland Medical Devices has received Food and Drug Administration (FDA) clearance to market Kinesia, a quantitative motor assessment system.

2 May 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Largest-ever Parkinson's disease trials

Researchers with the National Institute of Neurological Disorders and Stroke (NINDS) have initiated one of the largest-ever Parkinson's disease clinical trials.

7 Apr 2007

Creatine may help Parkinson's patients by giving an energy boost to dying cells

Whether a supplement used by athletes to boost energy levels and build muscle can slow progression of Parkinson's disease is the focus of a North American study.

22 Mar 2007

Parkinson's disease affects more than just motor control

Although Parkinson's disease is most commonly viewed as a "movement disorder," scientists have found that the disease also causes widespread abnormalities in touch and vision - effects that have now been verified using functional magnetic resonance imaging (fMRI) of the brain.

17 Oct 2006